MétaCan
Menu
Back to cohort
Record W4404137834 · doi:10.1183/13993003.00691-2024

Patient-centred composite scores as tools for assessment of response to biological therapy for paediatric and adult severe asthma

2024· article· en· W4404137834 on OpenAlexafffund
Ekaterina Khaleva, Christopher E. Brightling, Thomas Eiwegger, Alan Altraja, Philippe Bégin, Katharina Blümchen, Apostolos Bossios, Arnaud Bourdin, Anneke Ten Brinke, Guy Brusselle, Roxana Silvia Bumbăcea, Andrew Bush, Thomas B. Casale, Graham W. Clarke, Rekha Chaudhuri, Kian Fan Chung, Courtney Coleman, Jonathan Corren, A. Deschildre, Ratko Djukanović, Katrien Eger, Andrew Exley, Louise Fleming, Stephen J. Fowler, Erol Gaillard, Monika Gappa, Atul Gupta, Hans Michael Haitchi, Simone Hashimoto, Liam G. Heaney, Gunilla Hedlin, Markaya Henderson, Hua Wen, David J. Jackson, Bülent Karadağ, Constance H. Katelaris, Mariko Siyue Koh, Matthias Kopp, Gerard H. Koppelman, Inger Kull, Ramesh Kurukulaaratchy, Ji‐Hyang Lee, Vera Mahler, Mika J. Mäkelä, Matthew Masoli, Alexander G. Mathioudakis, Ángel Mazón, Erik Melén, Katrin Milger, Alexander Mœller, Clare Murray, Prasad Nagakumar, Parameswaran Nair, Jenny Negus, Antonio Nieto, Nikolaos G. Papadopoulos, James Y. Paton, Mariëlle W. Pijnenburg, Katharine C. Pike, Celeste Porsbjerg, Anna Rattu, Hitasha Rupani, Franca Rusconi, Niels W. Rutjes, Sejal Saglani, Paul Seddon, Salman Siddiqui, Florian Singer, Tomoko Tajiri, Steve Turner, John W. Upham, Susanne J. H. Vijverberg, Peter Wark, Michael E. Wechsler, Valentyna Yasinska, Graham Roberts

Bibliographic record

VenueEuropean Respiratory Journal · 2024
Typearticle
Languageen
FieldMedicine
TopicAsthma and respiratory diseases
Canadian institutionsHospital for Sick ChildrenSt. Joseph’s Healthcare HamiltonCentre Hospitalier de l’Université de MontréalMcMaster UniversityCentre Hospitalier Universitaire Sainte-JustineUniversity of Toronto
FundersNIHR Leicester Biomedical Research CentreNIHR Imperial Biomedical Research CentreManchester Biomedical Research CentreGenentechNational Institute for Health Research Southampton Biomedical Research CentreEngineering and Physical Sciences Research CouncilBausch HealthKarl-Franzens-Universität GrazInnovative Medicines InitiativeShionogiUniversiteit van AmsterdamEuropean Respiratory SocietyNestlé Health ScienceRijksuniversiteit GroningenCelltrionPfizerIncyteEuropean Federation of Pharmaceutical Industries and AssociationsCelldex TherapeuticsAAIR CharityUniversity of SouthamptonImperial Experimental Cancer Medicine CentreVertex PharmaceuticalsChiesi FarmaceuticiUniversity of OtagoRegeneron PharmaceuticalsNational Institute for Health and Care ResearchMedical Research CouncilTeva Pharmaceutical IndustriesKarolinska InstitutetZonMwAimmune TherapeuticsEli Lilly and CompanyAstraZenecaNovartis PharmaEuropean CommissionSanofiCerecorAmgenMedizinische Universität GrazGlaxoSmithKline
KeywordsMedicineAsthmaQuality of life (healthcare)Physical therapyIntensive care medicinePediatricsInternal medicineNursing

Abstract

fetched live from OpenAlex

BACKGROUND: We have previously developed Core Outcome Measures sets for Severe Asthma (COMSA) by multi-stakeholder consensus. There are no patient-centred tools to quantify response to biological therapies for severe asthma. We aimed to develop paediatric and adult CompOsite iNdexes For Response in asthMa (CONFiRM) incorporating clinical parameters and patient-reported quality of life. METHODS: International expert healthcare professionals and patients with severe asthma were invited to 1) develop consensus levels of clinically relevant changes for each outcome measure within COMSA, 2) use multicriteria decision analysis to develop the CONFiRM scores and 3) assess their internal validity. A separate group of healthcare professionals evaluated CONFiRM's external validity. RESULTS: Five levels of change for each COMSA outcome were agreed. Severe exacerbations and maintenance oral corticosteroid use were rated as the most important in determining both paediatric and adult CONFiRM scores. There was strong agreement between healthcare professionals and patients, although patients assigned greater importance to quality of life. The CONFiRM score quantified response to a biologic from -31 (deterioration) to 69 (best possible response). Paediatric and adult CONFiRMs had good discriminative ability for a sufficient (area under the curve ≥0.92) and a substantial (area under the curve ≥0.95) response to biologics. Both CONFiRMs demonstrated excellent external validity (Spearman correlation coefficients 0.9 and 0.8 for paediatric and adult, respectively; p<0.0001). CONCLUSIONS: We have developed novel patient-centred paediatric and adult CONFiRMs that include quality of life measures. CONFiRMs should allow a more holistic understanding of response for the patient and a standardised assessment of the effectiveness of biologics between studies. Further research is needed to prospectively validate CONFiRM scores.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.019
metaresearch head score (Gemma)0.040
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.019
Threshold uncertainty score0.098

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0190.040
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0030.002
Science and technology studies0.0000.001
Scholarly communication0.0010.001
Open science0.0010.002
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.041
GPT teacher head0.316
Teacher spread0.275 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations20
Published2024
Admission routes2
Has abstractyes

Explore more

Same venueEuropean Respiratory JournalSame topicAsthma and respiratory diseasesFrench-language works237,207